Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Similars in SciELO
Share
Revista Médica La Paz
On-line version ISSN 1726-8958
Abstract
TAPIA MARCA, Ramiro and VILLARROEL SALDIAS, Patricia. TOXIC EPIDERMAL NECROLYSIS, A CASE REPORT. Rev. Méd. La Paz [online]. 2021, vol.27, n.1, pp.38-42. ISSN 1726-8958.
Introduction: Toxic epidermal necrolysis (NET) are more severe skin reactions that occur in children. Medications are the main inducers of the problem. Human intravenous immunoglobulin (IGIV) has been used in autoimmune skin problems, including severe skin reactions from medications. Case report: Six-year-old patient with a history of having received third generation cephalosporin 3 weeks previously, hospitalized for a clinical picture of three days with thermal rises, rhinorrhea, sneezing, nausea, odynophagia, dysphagia, hyporexia, conjunctival hyperemia, cough, episodes of desaturation and skin rash that started on the face and spread to the trunk and extremities. Physical exam. Decayed, feverish patient, in poor general condition, appearance of maculopapular erythematous skin lesions with rapid evolution to formation of blisters with detachment of the epidermis (Nikolski positive), with involvement greater than 30% of body surface. Non-purulent conjunctivitis was observed, erythema and bleeding gums and lips, report of pathological anatomy of cutaneous lesions concluded in NET. IGIV was administered at 1 g/kg/dose/day. On the second day and second dose, the skin lesions improved. Discussion. IVIG has been used in children with severe drug-induced skin reactions, with a favorable response, from the 2nd dose of administration.
Keywords : Toxic epidermal necrolysis; rash; immunoglobulin; macular lesions.